March 12, 2020
The three legislative proposals below would help strengthen biosimilar adoption and each is designed to ensure savings for patients and Medicare.
March 4, 2020
Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a study released by Pacific Research Institute.
February 27, 2020
Physicians give their testimonials about how biosimilars are safe, effective and allow them to elevate clinical care for their patients.
biosimilars year in review
January 30, 2020
2019 was a whirlwind year for biosimilars, highlighted by a record 10 U.S. Food and Drug Administration (FDA) approvals and increased uptake and utilization rates by payers.
biosimilars in the united states
November 25, 2019
As biosimilars become more widely available in the United States, they expand therapeutic options, enhancing the likelihood that patients will be able to begin treatment with biologic medicines.
November 21, 2019
The Biosimilars Council just wrapped our annual GRx+Biosims Conference, discussing greater access to generic and biosimilar medicines for patients.

Want to keep up to date with the biosimilars industry?

Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.